Home
Conditions
Neuroinflammatory Diseases

Clinical trial condition

Neuroinflammatory Diseases

Explore clinical trials studying Neuroinflammatory Diseases. Study availability and eligibility vary by location and protocol.

1,039 public trials 116 recruiting studies

Refine in advanced search Browse all conditions

Neuroinflammatory Diseases trial results

Completed

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

NCT00894686

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchnerstr.17 Oberösterreich, Austria

Untergraben 2 Oberösterreich, Austria

Dr. Ulrich Behre Baden-Württemberg, Germany

Niepubliczny Zakład Opieki Zdrowotnej Ośrodek Zdrowia w Lipsku Zamość, Poland

View Trial Details

Completed

Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process

NCT01650636

Conditions: Chronic Disease, Chronic Fatigue Syndrome, Disease Attributes, +9 more
Locations: Department of Psychology University of Miami Coral Gables, Florida, United States

View Trial Details

Completed

Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine

NCT01567865

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: ICDDR,B Dhaka, Bangladesh

View Trial Details

Completed

The Feasibility, Acceptability and Clinical Utility of a New Remote-mobile Technology Intervention (ASARM) for CFS/ME in a Paediatric Population

NCT02082730

Conditions: Chronic Disease, Chronic Fatigue Syndrome, Disease Attributes, +9 more
Locations: Central Manchester University Hospitals NHS Foundation Trust Harrington Building Manchester, United Kingdom

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

NCT01337167

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +34 more
Locations: Not specified

View Trial Details

Completed

A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

NCT01340937

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +34 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months

NCT03671616

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Cevaxin Panama City, Panama

View Trial Details

Completed

3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

NCT02347423

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Hospital Maternidad Nuestra de la Altagracia Santo Domingo, Dominican Republic

View Trial Details

Completed

Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age

NCT03025750

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Cevaxin Panama City, Panama

View Trial Details

Completed

Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months

NCT03032419

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: 5 sites in Philippines Manila, Philippines

View Trial Details

Neuroinflammatory Diseases

Neuroinflammatory Diseases trial results

Related conditions